UT Southwestern Medical Center has been awarded a four-year grant from the Amgen Foundation to provide hands-on laboratory experience to undergraduate students across the North Texas region through the Amgen Scholars Program.
A new study from UT Southwestern quantifies for the first time how quickly these rapid advancements in genomics may benefit patients. Research published in JAMA Pediatrics includes a five-year review of more than 300 epilepsy cases that showed nearly a third of children had a change in diagnosis based on new data.
Researchers at UT Southwestern have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.
Biophysicist Dr. Michael Rosen – whose research is at the forefront of work revealing the fundamental process of protein phase transitions within the cell – today became UT Southwestern’s first Allen Distinguished Investigator
Dr. W. P. Andrew Lee, a world leader in hand transplantation at Johns Hopkins University School of Medicine, will become the new Executive Vice President for Academic Affairs, Provost, and Dean, UT Southwestern Medical School, effective Feb. 4, 2019.
New findings raise the possibility of a novel treatment for this subtype of blood and bone marrow cancer – known as acute myeloid leukemia or AML – by attacking a harmful molecule found on the cancerous cells and also reactivating the body’s white blood cells to fight them.
Charis Curbo says most of the time she doesn’t think about her NF1 and the thousands of tumors coating her back, her trunk, and other areas of her skin. “I’m just who I am. I’ll wear tank tops no matter what.”
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific advance could slow the development of these tumors.
UT Southwestern biochemist Dr. Zhijian “James” Chen today was named winner of the prestigious 2019 Breakthrough Prize in Life Sciences for his discovery of the cGAS enzyme that launches the body’s immune defense against infections and cancers. That enzyme patrols the cell’s interior and triggers the immune system in response to DNA.
UT Southwestern Medical Center has received the 2018 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education.
UT Southwestern Professor Dr. Sean Morrison, Director of the Children’s Medical Center Research Institute (CRI) at UT Southwestern, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
UT Southwestern researchers attempting to transform supporting brain cells into neurons instead reprogrammed mature inhibitory neurons into a different type of neuron that creates the neurotransmitter lost in Parkinson’s disease.
By injecting patients with stem cells engineered to repair the central nervous system – called progenitor cells – UT Southwestern scientists are working to establish the first treatment that can repair spinal cords inflamed by transverse myelitis.
By injecting patients with stem cells engineered to repair the central nervous system – called progenitor cells – UT Southwestern scientists are working to establish the first treatment that can repair spinal cords inflamed by transverse myelitis.
William P. Clements Jr. University Hospital has received a national Rising Star Award for improved quality and safety efforts, ranking it within the country’s top 25 academic medical center hospitals.
Drinking an additional 1.5 liters of water daily can reduce recurring bladder infections in premenopausal women by nearly half, a yearlong study of otherwise healthy women with a history of repeated infections has found.
Two UT Southwestern faculty members have been awarded prestigious National Institutes of Health (NIH) Director’s New Innovator Awards for high-risk, high-reward research.
Drinking an additional 1.5 liters of water daily can reduce recurring bladder infections in premenopausal women by nearly half, a yearlong study of otherwise healthy women with a history of repeated infections has found.
A study that reviewed genetic testing results from 1.45 million individuals found that nearly 25 percent of “variants of uncertain significance” were subsequently reclassified – sometimes as less likely to be associated with cancer, sometimes as more likely.
The Susan G. Komen organization has awarded a $600,000 research grant to Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center.
The family’s hope for Willow stems from a gene therapy center at UT Southwestern Medical Center where leading experts are engineering innovative treatments for some of the world’s rarest brain diseases.
Adding more evidence to the comparison between radiation therapy and surgery in treating an increasingly diagnosed head and neck cancer, a new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness of the two therapies.
UT Southwestern researchers today report the first use of CRISPR genome-wide screening to identify a gene that helps cells resist flavivirus infection.
The FSMB Foundation – the philanthropic arm of the Federation of State Medical Boards - has widened its grantmaking with a new program that supports the work of diverse research and educational projects through “mini-grants” of up to $5,000 each. The grants are designed to encourage research or educational efforts that increase awareness and understanding of trends and issues impacting medical regulation, as well as patient safety and health care quality overall.
Scientists for the first time have used CRISPR gene editing to halt the progression of Duchenne muscular dystrophy (DMD) in a large mammal, according to a study by UT Southwestern that provides a strong indication that a lifesaving treatment may be in the pipeline.
Heart attack patients given a different type of breathing tube by paramedics had better survival rates than those treated by traditional intubation breathing tube methods – findings that could potentially save more than 10,000 lives annually, researchers report.
A team of investigators used intraoperative infusions of labeled glucose in patients about to have surgery to remove the kidney cancer to assess how the tumors use glucose.
In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.
UT Southwestern’s gene therapy center is trailblazing a series of clinical trials for rare neurological diseases in which a single gene missing from the patient’s DNA can be packaged into a harmless virus and delivered into brain cells.
Baylor Scott & White Health leads the state of Texas in the number of accolades earned in U.S. News & World Report's "America's Best Hospitals" 2018-19 list, released today. Sixteen Baylor Scott & White hospitals were recognized, with two receiving national rankings.
UT Southwestern Medical Center has retained its listing as the No. 1-ranked hospital in Dallas-Fort Worth and No. 2 in Texas, while ranking nationally among the top 50 programs in seven clinical specialty areas, according to U.S. News & World Report’s annual Best Hospitals listings.
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those most at risk for 30-day readmission, researchers from UT Southwestern found.
Blue-light cystoscopy has previously been available at some institutions, including UT Southwestern, for use in the operating room, but it wasn’t available in a flexible scope until now.
A new study from UT Southwestern quantifies for the first time how quickly these rapid advancements in genomics may benefit patients. Research published in JAMA Pediatrics includes a five-year review of more than 300 epilepsy cases that showed about a third of children had a change in diagnosis based on new data. In some cases, the review helped doctors prescribe a more effective treatment.
Connecting two previously unrelated insights about the formation of pediatric kidney cancer, researchers at UT Southwestern Medical Center have uncovered the means by which the cancer continues to grow, providing potential targets for more effective treatments in the future.
In recognition of the need for a national coordinated and collective response to the epidemic of opioid addiction in the U.S., the Federation of State Medical Boards (FSMB) is partnering with the National Academy of Medicine (NAM) and 35 organizations to form the Action Collaborative on Countering the U.S. Opioid Epidemic. The public-private partnership is made up of organizations representing federal, state, and local governments, health systems, associations and provider groups, health education and accrediting institutions, pharmacies, payers, industry, nonprofits, and academia.
A team of researchers led by cardiologists at UT Southwestern Medical Center has developed a new online tool to more accurately predict who among those ages 40-65 is at the highest risk of suffering a heart attack or stroke in the next 10 years.
Texas Health Resources and UT Southwestern Medical Center joined with Frisco city leaders to mark a milestone in the construction of Texas Health Hospital Frisco with a ‘topping out’ event.
Marilyn Gibson, 81, is part of a UT Southwestern Medical Center clinical trial testing a one-time, high-dose and highly focused radiation treatment called stereotactic radiotherapy for early-stage breast cancer.
Scientists have discovered a “Big Bang” of Alzheimer’s disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.
A DNA-sensing enzyme forms droplets that act as tiny bioreactors creating molecules to stimulate innate immunity – the body’s first response to infection, UT Southwestern researchers report.
Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in small cell lung cancer (SCLC) that can be targeted by existing drug therapies.
Using a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 genetic changes that can contribute to rhabdomyosarcoma, an aggressive childhood cancer.